title: Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction.
abstract: OBJECTIVE
  Results for implantation efficiency and effective improvement of cardiac function in the field of mesenchymal stem cells (MSCs) are controversial. To attempt to clarify this debate, we utilized magnetic resonance imaging (MRI) and near-infrared optical imaging (OI) to explore the effects of different delivery modes of mesenchymal stem cells on cell retention time and cardiac function after myocardial infarction (MI).
  
  
  METHODS
  Rat MSCs were labeled with superparamagnetic iron oxide nanoparticles and 1, 1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine, 4-chlorobenzenesulfonate salt (DiD) for noninvasive cell tracking in a rat MI model. Rats underwent coronary artery ligation and were randomized into three experimental groups: intravenous (IV), intramyocardial (IM), and a control group. The first two groups referred to the route of delivery of the transplanted dual-labeled MSCs; whereas the control group was given an IV injection of serum-free medium one day post-MI. Cellular engraftment was determined 1 day and 7 days post cell delivery by measuring the iron and optical signals in explanted organs. Prussian blue staining and fluorescent microscopy were performed on histological sections for iron and DiD, respectively. Cardiac function was measured by echocardiography on day 7.
  
  
  RESULTS
  The cardiac function of the IM group increased significantly compared to the IV and control groups at day 7. In the IM group, labeled cells were visualized in the infracted heart by serial MRI, and the intensity by OI was significantly higher on day 1. In the IV group, the heart signals were significantly attenuated by dual-modal tracking at two time points, but the lung signals in OI were significantly stronger than the IM group at both time points.
  
  
  CONCLUSIONS
  IM injection of MSCs increased cell engraftment within infarcted hearts and improved cardiac function after MI. However, IV infusion has a low efficacy due to the cell trapping in the lung. Therefore, direct injection may provide an advantage over IV, with regard to retention of stem cells and protection of cardiac function.
authors: Department of Cardiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, Jiangsu, China.
authors: Yefei
authors: Y
authors: Li
authors: Yuyu
authors: Y
authors: Yao
authors: Zulong
authors: Z
authors: Sheng
authors: Yanxiaoxiao
authors: Y
authors: Yang
authors: Genshan
authors: G
authors: Ma
references: J Am Coll Cardiol. 2007 Jun 19;49(24):2373-4
references: 17572255
references: J Cell Mol Med. 2010 May;14(5):1078-82
references: 20646127
references: Circ Res. 2009 May 22;104(10):1209-16
references: 19407239
references: Circulation. 2003 May 13;107(18):2290-3
references: 12732608
references: J Cardiovasc Magn Reson. 2006;8(2):327-33
references: 16669175
references: Curr Opin Pharmacol. 2008 Apr;8(2):211-8
references: 18291721
references: Circulation. 2003 Sep 9;108 Suppl 1:II247-52
references: 12970241
references: Toxicol Lett. 2010 Jun 2;195(2-3):119-26
references: 20303399
references: Pediatr Res. 2008 Nov;64(5):488-94
references: 18614963
references: Prog Cardiovasc Dis. 2007 May-Jun;49(6):414-20
references: 17498521
references: Stem Cells. 2007 Nov;25(11):2936-44
references: 17690182
references: Curr Opin Biotechnol. 2007 Feb;18(1):38-45
references: 17196814
references: Handb Exp Pharmacol. 2007;(180):195-218
references: 17554510
references: Singapore Med J. 2009 Oct;50(10):935-42
references: 19907881
references: Circ Res. 2010 May 28;106(10):1613-23
references: 20508201
references: Heart Lung Circ. 2009 Jun;18(3):171-80
references: 19081302
references: Regen Med. 2007 Mar;2(2):107-9
references: 17465743
references: Eur Radiol. 2008 Oct;18(10):2021-32
references: 18506449
references: Circulation. 2003 Aug 19;108(7):863-8
references: 12900340
references: Shock. 2007 Oct;28(4):375-83
references: 17577135
references: Coron Artery Dis. 2005 Mar;16(2):93-7
references: 15735401
references: Crit Care Med. 2007 Nov;35(11):2587-93
references: 17828039
references: Eur Heart J. 2006 May;27(9):1114-22
references: 16510464
references: Heart Fail Rev. 2010 Jan;15(1):1-14
references: 19238541
references: Lancet. 2006 Jan 14;367(9505):113-21
references: 16413875
references: Int J Cardiol. 2006 Aug 10;111(2):231-9
references: 16246440
references: Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H533-42
references: 18539761
references: Mol Imaging Biol. 2011 Apr;13(2):303-13
references: 20552286
references: Curr Opin Organ Transplant. 2009 Feb;14(1):79-84
references: 19337151
references: Circ Res. 2004 Jul 9;95(1):9-20
references: 15242981
references: N Engl J Med. 2006 Sep 21;355(12):1199-209
references: 16990383
references: Biochem Biophys Res Commun. 2008 Sep 12;374(1):11-6
references: 18586003
references: Circulation. 2003 Apr 29;107(16):2134-9
references: 12695305